Dear Doctor - Participate in the Survey on breast cancer " The American Cancer Society’s most recent estimates for breast cancer in the United States are for 2018. In 2018, an estimated 266,120 new cases of invasive breast cancer will be diagnosed in women in the U.S. This includes 88060 cases of ductal carcinoma in situ (DCIS), which is a non-invasive form of breast cancer. Additionally, it is estimated that 63,960 women will die from breast cancer this year. However, death rates have been decreasing since 1989 due largely to improvements in screening and treatment advances. It is estimated that there are 3,410,000 women alive today who have been diagnosed with breast cancer at some point during their lives. Risk factors for developing breast cancer include: • being female and getting older – about two out of three invasive breast cancers are found in women who are 65 or older; • personal history of certain types of cancer – including ovarian cancer, ductal carcinoma in situ (DCIS), and lobular carcinoma in situ (LCIS); • family history of breast cancer – about 5 to 10% of invasive breast cancers are thought to be hereditary; • having dense breasts – denser breasts have more connective and glandular tissue than fatty tissue and can be more difficult to evaluate on a mammogram; • previous abnormal breast biopsy – an abnormal biopsy is one where atypical cells are found; Participate in Surveys "
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation